{"title":"获得许可的抗感染性造血坏死病毒(IHNV) DNA疫苗。","authors":"Marta Alonso, Jo-Ann C Leong","doi":"10.2174/1872215611307010009","DOIUrl":null,"url":null,"abstract":"<p><p>This article reviews some of the recent patents on DNA vaccines against fish viruses, in particular against the novirhabdovirus infectious hematopoitic necrosis virus (IHNV). Although very effective in protecting fish against IHNV, only one DNA vaccine has been approved to date for use in Canada. In Europe and in US, its commercialization is restricted due to safety concerns.</p>","PeriodicalId":74646,"journal":{"name":"Recent patents on DNA & gene sequences","volume":"7 1","pages":"62-5"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1872215611307010009","citationCount":"81","resultStr":"{\"title\":\"Licensed DNA Vaccines against Infectious Hematopoietic Necrosis Virus (IHNV).\",\"authors\":\"Marta Alonso, Jo-Ann C Leong\",\"doi\":\"10.2174/1872215611307010009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This article reviews some of the recent patents on DNA vaccines against fish viruses, in particular against the novirhabdovirus infectious hematopoitic necrosis virus (IHNV). Although very effective in protecting fish against IHNV, only one DNA vaccine has been approved to date for use in Canada. In Europe and in US, its commercialization is restricted due to safety concerns.</p>\",\"PeriodicalId\":74646,\"journal\":{\"name\":\"Recent patents on DNA & gene sequences\",\"volume\":\"7 1\",\"pages\":\"62-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1872215611307010009\",\"citationCount\":\"81\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent patents on DNA & gene sequences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1872215611307010009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on DNA & gene sequences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872215611307010009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Licensed DNA Vaccines against Infectious Hematopoietic Necrosis Virus (IHNV).
This article reviews some of the recent patents on DNA vaccines against fish viruses, in particular against the novirhabdovirus infectious hematopoitic necrosis virus (IHNV). Although very effective in protecting fish against IHNV, only one DNA vaccine has been approved to date for use in Canada. In Europe and in US, its commercialization is restricted due to safety concerns.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
